Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.1M | 9.7M | 4.3M | 3.8M |
| Cost of revenue | 4.8M | 8.7M | 5.0M | 4.4M |
| Gross profit | 261K | 1.1M | -642K | -655K |
| Operating expense | ||||
| Research & development | 25.9M | 22.4M | 24.2M | 29.1M |
| Selling general and admin | 16.9M | 13.1M | 20.7M | 20.9M |
| Other operating expenses | — | — | — | — |
| Operating income | -42.6M | -34.5M | -45.6M | -50.6M |
| Non operating interest income | ||||
| Income | 2.4M | 2.6M | 2.9M | 3.3M |
| Expense | 1.7M | 1.7M | 1.7M | 1.7M |
| Other income expense | 18.1M | -2.7M | 24.0M | -71.6M |
| Pretax income | -23.7M | -36.3M | -20.4M | -120.5M |
| Tax provision | -162K | 1.2M | 2.2M | -4.6M |
| Net income | -23.5M | -37.5M | -22.6M | -115.9M |
| Basic EPS | -0.1 | -0.2 | -0.1 | -0.7 |
| Diluted EPS | -0.1 | -0.2 | -0.3 | -0.7 |
| Basic average shares | 191.3M | 185.0M | 176.7M | 172.4M |
| Diluted average shares | 191.3M | 185.0M | 176.9M | 172.4M |
| EBITDA | -29.3M | -21.9M | -38.5M | -41.1M |
| Net income from continuing op. | -23.5M | -37.5M | -22.6M | -115.9M |
| Minority interests | 21K | -13K | 102K | 75K |
| Preferred stock dividends | — | — | — | — |